Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells. (2022)

Peer-Reviewed Study · Deokbae Park; Jung-Hee Lee; Sang-Pil Yoon · September 1, 2022

Deokbae Park et al., 2022-09-01: Park et al. compare wild-type and 5-FU-resistant SNU-C5 colorectal cells and find the resistant cells shift towards ferroptosis and ferroptosis-augmented apoptosis with less caspase-8 and p53 activation.

When compared with wild-type SNU-C5 cells, 5-fluorouracil-resistant SNU-C5 cells showed reduced autophagy, increased ferroptosis and ferroptosis-augmented apoptosis, and less activation of caspase-8 and p53.

Deokbae Park et al., 2022-09-01: Park et al. compare wild-type and 5-FU-resistant SNU-C5 colorectal cells and find the resistant cells shift towards ferroptosis and ferroptosis-augmented apoptosis with less caspase-8 and p53 activation. Study type: colorectal cancer cell lines (SNU-C5 wild-type and 5-FU-resistant). N: not applicable. Country: Korea (Jeju National University; Chosun University). Dose: not stated in the abstract text captured. Funder: not stated in the record. Declared conflicts: 'The authors declare no conflicts of interest.' Comparator: wild-type SNU-C5 and albendazole. This is the autophagy/ferroptosis arm of C4 and also the C5 resistance lead. Also filed as FBA-20, FBC-25, FBA-13 (claims C2, C3, C4, C5). Study type: lab.